Showing results (31-40 of 57) with videos related to
Sort By:
Pageof 6
Hepatology (Baltimore, Md.)|December 23, 2021
Angiotensin-converting enzyme inhibitors prevent liver-related events in nonalcoholic fatty liver diseaseXinrong Zhang, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip, et al.Alimentary Pharmacology & Therapeutics|September 6, 2025
Comparative Risk of Hepatitis B Virus Reactivation in Patients Receiving Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitors for Liver CancerDorothy Cheuk-Yan Yiu, Jimmy Che-To Lai, Landon Long Chan, et al.Gastroenterology|July 13, 2026
Long-term incidence of hepatocellular carcinoma after hepatitis B surface antigen seroclearanceSoleiman El-Debeiky, Tony Hiu-Fung Lam, Mandy Sze-Man Lai, et al.JHEP Reports : Innovation in Hepatology|August 7, 2023
Baveno VII criteria for recompensation predict transplant-free survival in patients with hepatitis B-related decompensated cirrhosisVicki Wing-Ki Hui, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, et al.Hepatology (Baltimore, Md.)|March 25, 2022
Risk of liver-related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver diseaseXinrong Zhang, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 24, 2025
Enhanced Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma Using Age-male-albumin-bilirubin-platelet (aMAP) and Liver Stiffness Assessed by Vibration-controlled Transient ElastographyHye Yeon Chon, Hyung Joon Yim, Seok-Jae Heo, et al.Hepatology (Baltimore, Md.)|July 5, 2022
Age and the relative importance of liver-related deaths in nonalcoholic fatty liver diseaseHuapeng Lin, Terry Cheuk-Fung Yip, Xinrong Zhang, et al.Hepatology (Baltimore, Md.)|April 29, 2023
Duration of type 2 diabetes and liver-related events in nonalcoholic fatty liver disease: A landmark analysisXinrong Zhang, Terry Cheuk-Fung Yip, Yee-Kit Tse, et al.Nature Reviews. Gastroenterology & Hepatology|August 15, 2024
Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directionsLung-Yi Mak, Ken Liu, Sakkarin Chirapongsathorn, et al.Alimentary Pharmacology & Therapeutics|May 19, 2025
Long-Term Dynamic Changes of Alanine Aminotransferase Levels Are Associated With Liver-Related Events in Nucleos(t)ide Analogue-Treated Chronic Hepatitis B Patients in ChinaRong Fan, Ning Yu, Jimmy Che-To Lai, et al.Pageof 6